This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Gilead Sciences Inc (GILD)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 12.06B 3.06B 2.57B 2.79B
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -2.58B -315.30M 197.99M -375.74M
(Increase) Decrease in Inventories 143.00M -343.14M -349.92M -200.79M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -289.00M -97.67M 117.48M 428.94M
(Decrease) Increase In Other Current Liabilities 2.55B 341.65M 317.59M 411.36M
(Increase) Decrease In Other Working Capital 31.00M 22.14M 23.25M -29.48M
Other Non-Cash Items 463.00M 363.86M 205.24M 263.32M
Net Cash From Continuing Operations 12.82B 3.10B 3.19B 3.64B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 12.82B 3.10B 3.19B 3.64B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 859.00M 0.00 0.00 9.44B
Purchases of Property, Plant & Equipment -557.00M -190.78M -397.05M -131.90M
Acquisitions 0.00 -378.64M -10.75B -588.61M
Purchases of Short-Term Investments -2.11B -256.70M -1.24B -5.13B
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.82B -254.35M -11.85B 3.59B
Issuance of Debt 10.47B 2.77B 2.36B 4.66B
Cash Used for Financing Activities
Issuance of Capital Stock 331.00M 313.08M 466.28M 211.74M
Repayment of Long-Term Debt -4.80B -4.44B -1.84B -651.55M
Repurchase of Capital Stock -5.35B -582.36M -667.04M -2.38B
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -3.68B -609.17M 244.84M -74.19M
Net Cash From Financing Activities -3.02B -2.54B 563.35M 1.76B
Effect of Exchange Rate Changes -56.00M 2.42M 7.91M -16.53M
Net Change in Cash & Cash Equivalents 7.91B 309.11M -8.08B 8.98B

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

GILD Gilead Sciences Inc

Chart of GILD

Analysts Ratings for GILD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 10 11
Moderate Buy 2 2 3 3
Hold 3 3 2 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

GILD Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs